Jessica Lewis-Gonzalez, PharmD, BCOP

Learn how pharmacists spot systemic mastocytosis sooner—using sensitive KIT testing, WHO/ICC criteria, and smarter referrals to improve outcomes.

Learn how pharmacists spot systemic mastocytosis sooner—using sensitive KIT testing, WHO/ICC criteria, and smarter referrals to improve outcomes.

Jessica Lewis-Gonzalez, PharmD, BCOP, discusses how pharmacists can layer mediator-symptom management with cytoreductive or targeted therapy in systemic mastocytosis (SM) and interdisciplinary communication.

Pharmacists play a crucial role in managing myelofibrosis, enhancing patient education, adherence, and financial navigation for optimal care.

Jessica Lewis-Gonzalez, PharmD, BCOP, discusses the management of hematologic and non-hematologic toxicities in cancer patients, emphasizing the importance of proactive monitoring and collaboration between clinicians and pharmacists.

Jessica Lewis-Gonzalez, PharmD, BCOP, discusses the challenges of managing myelofibrosis, from its heterogeneity and symptom burden to limited curative options.